Amount Raised
$101 Million
Round Type
Series E
WatertownBiotechnologyInvestors
Description
Lyndra Therapeutics®, a clinical-stage biopharmaceutical company, today announced the closing of a $101 million Series E financing round. The proceeds of the round, led by Sarissa Capital and including Sun Pharmaceutical Industries Limited [Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715], ("Sun Pharma" and includes its subsidiaries and/or associate companies) and Polaris Partners, will support the development of Lyndra’s pipeline, including oral weekly risperidone (LYN-005), which is near completion of a pivotal phase 3 study.
Quick answer
Lyndra Therapeutics, Inc. raised $101 Million in a Series E round, dated December 21, 2023. Investors: Polaris Partners, Sun Pharmaceutical Industries Limited and Sarissa Capital. Lyndra Therapeutics, Inc. is based in Watertown, Massachusetts, United States.
- How much did Lyndra Therapeutics, Inc. raise?
- Lyndra Therapeutics, Inc. raised $101 Million in a Series E round on December 21, 2023.
- Who invested in Lyndra Therapeutics, Inc?
- Polaris Partners, Sun Pharmaceutical Industries Limited and Sarissa Capital are named as investors in this round.
- What does Lyndra Therapeutics, Inc. do?
- Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, extended-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill..
- Where is Lyndra Therapeutics, Inc. based and how big is it?
- Lyndra Therapeutics, Inc. is based in Watertown, Massachusetts, United States. Fundz records about 83 employees.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Lyndra Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Algorithmic Biologics raised $2.5M (Pre-Series A) on February 3, 2024.
- Anbogen Therapeutics raised $13M (Series A) on February 2, 2024.
- Anbogen Therapeutics raised $13M (Funding Round) on February 2, 2024.
- Proniras raised $4.7M (Seed) on February 2, 2024.
- SPR Therapeutics raised $85M (Funding Round) on February 2, 2024.
- Tyra Biosciences raised $200M (Post-IPO Equity) on February 2, 2024.
Who to call at Lyndra Therapeutics, Inc., and when
A new round usually means Lyndra Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lyndra Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lyndra Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lyndra Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lyndra Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Lyndra Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.